Gemphire Therapeutics to Present at the Piper Jaffray Healthcare and LD Micro Main Event Conferences
LIVONIA, Mich., Nov. 17, 2016 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for the treatment of dyslipidemia and NAFLD/NASH, today announced …